SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-23-036896
Filing Date
2023-03-27
Accepted
2023-03-27 08:31:01
Documents
14
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A tm2310472d1_10ka.htm   iXBRL 10-K/A 253990
2 EXHIBIT 31.3 tm2310472d1_ex31-3.htm EX-31.3 3132
3 EXHIBIT 31.4 tm2310472d1_ex31-4.htm EX-31.4 3509
  Complete submission text file 0001104659-23-036896.txt   510851

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA nvct-20221231.xsd EX-101.SCH 3034
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvct-20221231_lab.xml EX-101.LAB 36510
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvct-20221231_pre.xml EX-101.PRE 23999
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2310472d1_10ka_htm.xml XML 5765
Mailing Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024
Business Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024 360-837-7232
Nuvectis Pharma, Inc. (Filer) CIK: 0001875558 (see all company filings)

IRS No.: 862405608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-41264 | Film No.: 23761523
SIC: 2834 Pharmaceutical Preparations